WallStreetZenWallStreetZen

NASDAQ: NRXP
Nrx Pharmaceuticals Inc Stock

$0.31+0.02 (+6.9%)
Updated Feb 28, 2024
NRXP Price
$0.31
Fair Value Price
$0.14
Market Cap
$25.60M
52 Week Low
$0.22
52 Week High
$1.20
P/E
-0.61x
P/B
-4.12x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$36.06M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-3.11
Operating Cash Flow
-$27M
Beta
0.48
Next Earnings
Mar 28, 2024
Ex-Dividend
N/A
Next Dividend
N/A

NRXP Overview

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NRXP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NRXP ($0.31) is overvalued by 110.5% relative to our estimate of its Fair Value price of $0.14 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NRXP ($0.31) is not significantly undervalued (110.5%) relative to our estimate of its Fair Value price of $0.14 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NRXP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NRXP due diligence checks available for Premium users.

Be the first to know about important NRXP news, forecast changes, insider trades & much more!

NRXP News

Valuation

NRXP fair value

Fair Value of NRXP stock based on Discounted Cash Flow (DCF)
Price
$0.31
Fair Value
$0.14
Overvalued by
113.95%
NRXP ($0.31) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NRXP ($0.31) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NRXP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NRXP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.61x
Industry
13.96x
Market
35.52x

NRXP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-4.12x
Industry
6.14x

NRXP's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.1M
Profit Margin
0%
NRXP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$13.1M
Liabilities
$19.3M
Debt to equity
-3.11
NRXP's short-term liabilities ($19.33M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NRXP's short-term assets ($13.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NRXP's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NRXP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.6M
Investing
-$2.0k
Financing
-$1.5M
NRXP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NRXP vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NRXP$25.60M+3.74%-0.61x-4.12x
LSTA$25.71M-1.89%-2.85x0.49x
FBRX$26.16M+5.11%-0.58x0.65x
UBX$24.86M-7.10%-0.53x0.69x
NRBO$24.84M+6.44%0.13x1.15x

Nrx Pharmaceuticals Stock FAQ

What is Nrx Pharmaceuticals's quote symbol?

(NASDAQ: NRXP) Nrx Pharmaceuticals trades on the NASDAQ under the ticker symbol NRXP. Nrx Pharmaceuticals stock quotes can also be displayed as NASDAQ: NRXP.

If you're new to stock investing, here's how to buy Nrx Pharmaceuticals stock.

What is the 52 week high and low for Nrx Pharmaceuticals (NASDAQ: NRXP)?

(NASDAQ: NRXP) Nrx Pharmaceuticals's 52-week high was $1.20, and its 52-week low was $0.22. It is currently -74.58% from its 52-week high and 38.01% from its 52-week low.

How much is Nrx Pharmaceuticals stock worth today?

(NASDAQ: NRXP) Nrx Pharmaceuticals currently has 83,919,554 outstanding shares. With Nrx Pharmaceuticals stock trading at $0.31 per share, the total value of Nrx Pharmaceuticals stock (market capitalization) is $25.60M.

Nrx Pharmaceuticals stock was originally listed at a price of $10.01 in Nov 20, 2017. If you had invested in Nrx Pharmaceuticals stock at $10.01, your return over the last 6 years would have been -96.95%, for an annualized return of -44.11% (not including any dividends or dividend reinvestments).

How much is Nrx Pharmaceuticals's stock price per share?

(NASDAQ: NRXP) Nrx Pharmaceuticals stock price per share is $0.31 today (as of Feb 28, 2024).

What is Nrx Pharmaceuticals's Market Cap?

(NASDAQ: NRXP) Nrx Pharmaceuticals's market cap is $25.60M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nrx Pharmaceuticals's market cap is calculated by multiplying NRXP's current stock price of $0.31 by NRXP's total outstanding shares of 83,919,554.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.